Clinical Trial Update: Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing hypofractionated versus conventional radiation therapy after prostate cancer surgery; study completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: NRG Oncology | Conditions: Prostate Adenocarcinoma, Stage I Prostate Adenocarcinoma AJCC v7 | Phase 3 | Status: COMPLETED | Results posted: 2022-06-06